BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yotsueda R, Tanaka S, Taniguchi M, Fujisaki K, Torisu K, Masutani K, Hirakata H, Kitazono T, Tsuruya K. Hemoglobin concentration and the risk of hemorrhagic and ischemic stroke in patients undergoing hemodialysis: the Q-cohort study. Nephrol Dial Transplant 2018;33:856-64. [PMID: 29237088 DOI: 10.1093/ndt/gfx305] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Toft G, Heide-Jørgensen U, van Haalen H, James G, Hedman K, Birn H, Christiansen CF, Thomsen RW. Anemia and clinical outcomes in patients with non-dialysis dependent or dialysis dependent severe chronic kidney disease: a Danish population-based study. J Nephrol 2020;33:147-56. [PMID: 31587136 DOI: 10.1007/s40620-019-00652-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
2 Song HY, Wei CM, Zhou WX, Hu HF, Wan QJ. Association between admission hemoglobin level and prognosis in patients with type 2 diabetes mellitus. World J Diabetes 2021; 12(11): 1917-1927 [PMID: 34888016 DOI: 10.4239/wjd.v12.i11.1917] [Reference Citation Analysis]
3 Lu Y, Jin H, Zhao Y, Li Y, Xu J, Tian J, Luan X, Chen S, Sun W, Zhang S, Xu S, Zhu F, Chen L, Mima D, Sun Y, Zhuoga C. Impact of Increased Hemoglobin on Spontaneous Intracerebral Hemorrhage. Neurocrit Care 2021. [PMID: 34313936 DOI: 10.1007/s12028-021-01305-1] [Reference Citation Analysis]
4 Kitamura M, Tateishi Y, Sato S, Kitamura S, Ota Y, Muta K, Yamashita H, Uramatsu T, Obata Y, Mochizuki Y, Nishikido M, Izumo T, Harada T, Funakoshi S, Matsuo T, Tsujino A, Sakai H, Mukae H, Nishino T. Association between serum calcium levels and prognosis, hematoma volume, and onset of cerebral hemorrhage in patients undergoing hemodialysis. BMC Nephrol 2019;20:210. [PMID: 31174486 DOI: 10.1186/s12882-019-1400-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Palaka E, Grandy S, van Haalen H, McEwan P, Darlington O. The Impact of CKD Anaemia on Patients: Incidence, Risk Factors, and Clinical Outcomes-A Systematic Literature Review. Int J Nephrol 2020;2020:7692376. [PMID: 32665863 DOI: 10.1155/2020/7692376] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Ravera M, Bussalino E, Paoletti E, Bellasi A, Di Lullo L, Fusaro M. Haemorragic and thromboembolic risk in CKD patients with non valvular atrial fibrillation: Do we need a novel risk score calculator? International Journal of Cardiology 2019;274:179-85. [DOI: 10.1016/j.ijcard.2018.07.066] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
7 Hung PH, Yeh CC, Hsiao CY, Muo CH, Hung KY, Tsai KJ. Erythropoietin Use and the Risk of Stroke in Patients on Hemodialysis: A Retrospective Cohort Study in Taiwan. J Am Heart Assoc 2021;10:e019529. [PMID: 34176302 DOI: 10.1161/JAHA.120.019529] [Reference Citation Analysis]
8 Tsai WH, Chuang SM, Liu SC, Lee CC, Chien MN, Leung CH, Liu SJ, Shih HM. Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: a systematic review and meta-analysis. Sci Rep 2021;11:15364. [PMID: 34321571 DOI: 10.1038/s41598-021-94945-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]